Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

Launched by DR.DR.IRMA BERNADETTE, SPKK (K) · Jul 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the genetic factors that may contribute to acne vulgaris, a common skin condition that causes pimples and skin irritation. Researchers are looking specifically at patients in Indonesia to see how genetics and geographical location might influence acne. The study will involve analyzing skin samples from participants and comparing their genetic profiles to better understand the condition.

If you are between 17 and 21 years old and have acne, you may be eligible to participate in this study. You would also need to have both parents available to take part, and they can be either affected by acne or not. Participants will need to sign an agreement to join the study and should be in good health, without other skin diseases or conditions. During the trial, participants can expect to provide skin samples and answer questions about their health and family history. This research aims to help improve our understanding of acne and may contribute to better treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males or females with AVB aged 17-21 years
• • Both parents of complete subjects with or without a history of acne vulgaris aged up to 60 years
• • Patients and parents are willing to participate in the study and sign informed consent.
• Exclusion Criteria:
• • Patients who have other inflammatory or infectious diseases especially on the face
• • Have genetic diseases or disorders
• • Diagnosed with primary or secondary immunodeficiency diseases
• • Using oral or systemic antibiotic, anti-inflammatory, retinoid or hormone therapy in the past month.